Geneticlines

Biobank that aims to gain more knowledge about the origin and treatment of (hereditary) diseases. Cohort

Biobank that aims to gain more knowledge about the origin and treatment of (hereditary) diseases.

Research into genetic disorders is complex and often requires a lot of information. To find out which changes in DNA are normal and which may cause a disease, it is necessary to compare DNA from sick and healthy people.

The GeneticLines biobank started in 2021 and prospectively collects phenotype information, biomaterials and genetic data from patients. With the data from Geneticlines, scientists can research the origin and treatment of (hereditary) diseases.

At the moment, all patients (>18 years) that visit our policlinics are prospectively included. In the near future, children will be included as well.
Please visit the UMCG Research Data Catalogue for more detailed information on our data and samples.

GeneticLines prospectively collects phenotype information, biomaterials and genetic data from patients, such as:
- general patient information (e.g. gender, date of birth);
- clinical history (e.g., phenotypes, comorbidities, family history;
- genetic data;
- DNA, RNA, serum, plasma, whole blood.
- UMCG Department Genetics
Geneticlines (in Dutch).

Relevance

How Geneticlines benefits to society

The discovery of the genetic origins of diseases allows prediction of the chance of occurrence of disorders that are (partly) genetically determined, so that preventive and therapeutic measures can be offered in a more targeted way. In addition, it will increasingly be possible to identify the sensitivity to (side effects of) medicines and to prescribe tailor-made medication.